000057926 001__ 57926
000057926 005__ 20191118100148.0
000057926 0247_ $$2doi$$a10.1155/2013/871689
000057926 0248_ $$2sideral$$a84172
000057926 037__ $$aART-2013-84172
000057926 041__ $$aeng
000057926 100__ $$aJimenez-Aragon, F.
000057926 245__ $$aRole of color doppler imaging in early diagnosis and prediction of progression in glaucoma
000057926 260__ $$c2013
000057926 5060_ $$aAccess copy available to the general public$$fUnrestricted
000057926 5203_ $$aThis longitudinal and prospective study analyzes the ability of orbital blood flow measured by color Doppler imaging (CDI) to predict glaucoma progression in patients with glaucoma risk factors. Patients with normal perimetry but having glaucoma risk factors and patients in the initial phase of glaucoma were prospectively included in the study and divided, after a five-year follow-up, into two groups: “Progression” and “No Progression” based on the changes in the Moorfields regression analysis (MRA) classification of Heidelberg retina tomograph (HRT). An orbital CDI was performed in all patients and the parameters obtained were correlated with changes in HRT. A logistic discrimination function (LDF) was calculated for ophthalmic artery (OA) and central retinal artery (CRA) parameters. Receiver operating characteristics curves (ROC) were used to assess the usefulness of LDFs to predict glaucomatous progression. A total of 71 eyes were included. End-diastolic velocity, time-averaged velocity, and resistive index in the OA and CRA were significantly different ( ) between the Progression and No Progression groups. The area under the ROC curves calculated for both LDFs was of 0.695 (OA) and 0.624 (CRA). More studies are needed to evaluate the ability of CDI to perform early diagnosis and to predict progression in glaucoma in eyes.
000057926 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000057926 590__ $$a0.0$$b2013
000057926 591__ $$aMEDICINE, RESEARCH & EXPERIMENTAL$$b123 / 124 = 0.992$$c2013$$dQ4$$eT3
000057926 591__ $$aBIOTECHNOLOGY & APPLIED MICROBIOLOGY$$b162 / 165 = 0.982$$c2013$$dQ4$$eT3
000057926 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000057926 700__ $$0(orcid)0000-0001-6258-2489$$aGarcia-Martin, E.$$uUniversidad de Zaragoza
000057926 700__ $$aLarrosa-Lopez, R.
000057926 700__ $$0(orcid)0000-0003-0437-0028$$aArtigas-Martín, J.M.$$uUniversidad de Zaragoza
000057926 700__ $$aSeral-Moral, P.
000057926 700__ $$0(orcid)0000-0003-2389-8282$$aPablo, L.E.$$uUniversidad de Zaragoza
000057926 7102_ $$11010$$2770$$aUniversidad de Zaragoza$$bDpto. Pediatría Radiol.Med.Fís$$cÁrea Radiol. y Medicina Física
000057926 7102_ $$11004$$2646$$aUniversidad de Zaragoza$$bDpto. Cirugía,Ginecol.Obstetr.$$cÁrea Oftalmología
000057926 773__ $$g2013 (2013), 871689 [11 pp]$$pBioMed res. int.$$tBioMed Research International$$x2314-6133
000057926 8564_ $$s2683351$$uhttps://zaguan.unizar.es/record/57926/files/texto_completo.pdf$$yVersión publicada
000057926 8564_ $$s98837$$uhttps://zaguan.unizar.es/record/57926/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000057926 909CO $$ooai:zaguan.unizar.es:57926$$particulos$$pdriver
000057926 951__ $$a2019-11-18-09:53:19
000057926 980__ $$aARTICLE